CETRARIA ISLANDICA (HOMEOLAB USA INC.)


Welcome to the PulseAid listing for the CETRARIA ISLANDICA drug offered from HOMEOLAB USA INC.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: HOMEOLAB USA INC.
NON-PROPRIETARY NAME: CETRARIA ISLANDICA
SUBSTANCE NAME: CETRARIA ISLANDICA SUBSP. ISLANDICA
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1995-10-11
END MARKETING DATE: 0000-00-00


CETRARIA ISLANDICA HUMAN OTC DRUG Details:

Item DescriptionCETRARIA ISLANDICA from HOMEOLAB USA INC.
LABELER NAME: HOMEOLAB USA INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 1([hp_X]/1)
START MARKETING DATE: 1995-10-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60512-6582_fdcb1441-b829-4ddf-a5b9-1a51624261ae
PRODUCT NDC: 60512-6582
APPLICATION NUMBER:

Other CETRARIA ISLANDICA SUBSP. ISLANDICA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
HOMEOLAB USA INC.CETRARIA ISLANDICA
Sanum Kehlbeck GmbH & Co. KGPleo Cerivi